Medical Tribune

CME Webinar

Oncology from an expert perspective: Diagnostic and therapeutic options in non-small cell lung cancer (NSCLC)

21 Oct 2022
14:00 - 19:35
online
SGMO | 6 Credits
SGAIM | F-003777 | 4 Credits
Registration for this event is no longer possible

Renowned experts present their opinions and recommendations as treating physicians on specific therapeutic concepts and options in lung cancer.

Language: English

Speakers

Dr. Wolf-Dieter Janthur
Leitender Arzt Onkologie, Kantonsspital Aarau, Aarau
Prof. Markus Jörger
Leitender Arzt / Leitung Klinische Forschungsabteilung, Klinik für Medizinische Onkologie und Hämatologie, Kantonsspital St. Gallen, St. Gallen
Prof. Maximilian Hochmair
Head of the pneumo-oncological outpatient clinic + day clinic, Wiener Gesundheitsverband, Klinik Florisdorf
Dr. Alex Friedlaender
Oncologist, Clinique Générale-Beaulieu, Genève
Dr. Hasna Bouchaab
Service d'oncologie médicale, Département d'oncologie UNIL CHUV, Lausanne

Program

14:00
14:05
Welcoming the participants
14:05
15:00
Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and Implications
(Dr. Wolf-Dieter Janthur)
15:00
16:00
Immunotherapies in good companionship: where do combination therapies make sense in advanced NSCLC – and where not?
(Prof. Markus Jörger)
16:00
16:30
Pause
16:30
17:30
Targeted therapies in lung cancer
(Prof. Maximilian Hochmair)
17:30
18:30
MSD: How to treat metastatic NSCLC in specific subgroups
(Dr. Alex Friedlaender)
18:30
19:30
AstraZeneca: Adjuvant/ Neo-adjuvant treatment options for NSCLC patients, focus EGFRm
(Dr. Hasna Bouchaab)
19:30
19:35
Round-up and good-byes
This webinar is possible due to the kind support of AstraZenaca, Novartis, MSD, Sanofi-Aventis and Takeda.
Logo AstraZeneca
Logo MSD
Logo Sanofi
Logo Takeda